The latest edition of Mississippi Hospitals magazine is available for download here. To receive the magazine in print, join an MHA society! For more information on how to have your hospital news featured in this magazine, contact Shawn Rossi at (800) 289-8884, (601) 368-3237 or email@example.com.
The State of Mississippi will receive nearly $2.5 million to help combat the Zika virus. More than $1 million of the funding will come from the Centers for Disease Control and Prevention, and $1.2 million will come through the CDC’s Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement.
Mississippi's health department says a second state resident has been infected with the dangerous bacteria called Vibrio vulnificus. Spokeswoman Liz Sharlot told WDAM-TV on July 21 that the person lives in Forrest County and was infected in Mississippi gulf waters.
Despite objections from Congress and the hospital industry, the Obama administration said it will soon publish star ratings summing up the quality of 3,662 hospitals. Nearly half will be rated as average, and hospitals that serve the poor will not score as well overall as will other hospitals, according to government figures released on July 21.
If you are working in any capacity to improve hospital quality and patient safety, this AHRQ toolkit – and the companion Webinars – are for you.
QI Toolkit overview: To support hospitals in their improvement efforts, AHRQ updated its ‘Toolkit for Using the AHRQ Quality Indicators: How to Improve Hospital Quality and Safety,’ which is now available*. The QI Toolkit serves as both a general ‘how to’ guide through the improvement process as well as a specific resource for improving performance on the AHRQ Quality Indicators (QIs). Use of the Toolkit has grown dramatically in recent years , spurred in part by the Centers for Medicare & Medicaid Services’ use of the AHRQ patient safety composite measure, PSI 90, in their Hospital Value-Based Purchasing program, Hospital-Acquired Condition (HAC) Reduction program, and Hospital Compare public report. The QI Toolkit is menu-driven, allowing hospitals to select those that are most appropriate to their improvement priorities and capacities. Each of the tools – by design – is adaptable to the needs of an individual hospital.
QI Toolkit is organized into the following modules:
Assessing Readiness to Change. Includes: fact sheets on the QIs, a slide presentation template to hospital board, a survey to self-assess readiness to change, and case studies of QI Toolkit users.
Applying QIs to Hospital Data. Includes: software instructions to calculate the QI rates, and guidance for coding and documentation.
Identifying Priorities for Quality Improvement. Includes: a measure prioritization worksheet, an example of a completed worksheet, and a slide presentation template aimed at engaging staff in the improvement process.
Implementing Evidence-Based Strategies to Improve Clinical Care. Includes: 25 indicator-specific clinical best practices, a project charter, a gap analysis, and an implementation plan.
Monitoring Progress and Sustainability of Improvements. Includes: a guide to support staff in tracking trends and monitoring progress for sustainable improvement.
Analyzing Return-on-Investment. Includes: a step-by-step method for calculating the return-on-investment for interventions to improve performance on an AHRQ QI, and an illustrative example of a return-on-investment calculation.
Other Quality Improvement Resources. Includes: an annotated list of related quality improvement guides and tools.
*To download ‘Toolkit for Using the AHRQ Quality Indicators: How to Improve Hospital Quality and Safety’, click here.
Two companion Webinars. For your convenience, the identical Webinar will be offered twice. AHRQ invites you to register for the Webinar that best fits your schedule. Webinar capacity is limited and so only the first Webinar date you select will be processed; if however registration for that date has closed, you will have the opportunity to register for the alternative date. Featured speakers include:Pam Owens, PhD, senior research scientist at AHRQ, RAND Corporation’s Peter Hussey, PhD, senior policy researcher, and Courtney Gidengil, MD, MPH, physician scientist, and Ellen Robinson, PT, a clinical quality specialist at Harborview Medical Center in Seattle.
Date #1: Monday, August 1, 2016. Time: 1:00-2:30 pm ET
The Centers for Medicare & Medicaid Services has extended the data submission deadline for the fiscal year 2017 Inpatient Psychiatric Facility Quality Reporting Program measures and for the first-quarter 2016 Hospital Inpatient Quality Reporting Program elective delivery measure due to the late start of web-based data collection. Participating providers may now submit the data via the web-based measures tools at the QualityNet Secure Portal through Aug. 26 at 11:59 p.m. PT.
The data submission deadline for hospital inpatient chart-abstracted clinical measures and healthcare- associated infection measures remains Aug. 15. CMS encourages providers to submit data at least two days early to allow time to address any submission issues. For further assistance, providers should contact the Outreach and Education Support Team and submit any changes to their contact information using the contact change form.
The American Hospital Association on July 15 urged the Food and Drug Administration to revise its draft compounding guidance to allow hospital and health system pharmacies to continue to distribute compounded drug products to other health care facilities in the same system. The AHA “strongly recommends that the FDA remove the arbitrary one-mile radius limitation and replace it with an alternative approach that would support the existing hospital and health system care delivery model and also put into place widely-vetted, evidence-based limits on anticipatory compounding in hospitals and health systems to ensure safe, high-quality patient care,” wrote Ashley Thompson, AHA senior vice president for public policy analysis and development.
Specifically, AHA recommends limiting the distribution of non-patient-specific sterile compounded drugs in hospitals and health systems based on the beyond-use date timeframes contained in USP Chapters 797 and 800. “This approach would limit the amount of a compounded drug that could be created and distributed without a prescription and would ensure its timely use,” AHA said.
The association also supports FDA’s proposals to limit the distribution of sterile drugs compounded in a hospital pharmacy prior to receipt of a patient-specific order to health care facilities owned and controlled by the same entity as the hospital pharmacy, and limit their administration to patients in those facilities pursuant to a specific prescription or order.